Leading Life Technologies is where better data become better diagnosis and cure.
Every decision counts in clinical practice. Leading Life Technologies is committed to providing more reliable data to help clinicians make those decisions with confidence. By using our patented assay platforms, clinicians can stay ahead of the latest developments in medical research and gain the evidence they need to strengthen their clinical decision-making and improve patient outcomes.
Leading Life Technologies (LLT) exploits its proprietary FocalTuning™ platform to provide life science and clinical research products and services. We focus on detecting sensitive biomarkers and low level analytes in complicated biological samples.
FocalTuningTM is a universal immunoassay platform, which can be tailored and applied in a variety of life science research and diagnostic areas. Monitoring PEG immunogenicity, particularly anti-PEG IgE, is one of the breakthrough applications of this technology. Welcome to visit peg.leadinglifetechnologies.com for more details.
As the first milestone, Life Technologies is paving the way for the next level of PEG anaphylaxis diagnosis.
Vision: A next-generation diagnostics company
Mission: Better data become better diagnosis and cure
Strategy: AI-enhanced Interdisciplinary
Purpose: Improving research and health